Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer
Open Access
- 28 January 2003
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (2) , 195-201
- https://doi.org/10.1038/sj.bjc.6600715
Abstract
We addressed in this study whether quantifying the extent of disease on bone scans can predict the disease death of patients with advanced prostate cancer using computer-assisted image analysis. Pretreatment radionuclide bone scans were reviewed in 56 patients with bone metastases from prostate cancer, and the percentage of the positive area on a bone scan (%PABS) was quantified automatically using a personal computer with the NIH Image program for estimation of the accurate extent of metastatic bone lesions on a bone scan. The significance of the %PABS as well as the other known prognostic factors was evaluated using univariate and multivariate Cox proportional hazards analysis. In univariate regression analysis, the %PABS (P=0.0155), serum alkaline phosphatase (P=0.0272), the tumour grade based on biopsy (P=0.044) and the number of bone lesions on bone scans (P=0.0388) were well associated with disease-specific survival. In multivariate analysis, the %PABS (P=0.0155, relative risk ratio 2.603), but not the other factors, was the independent predictor of the disease death. These results suggest that the %PABS is a novel parameter for predicting the prognosis of patients with advanced prostatic cancer.Keywords
This publication has 19 references indexed in Scilit:
- Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.2001
- PYRIDINOLINE CROSS-LINKED CARBOXYTERMINAL TELOPEPTIDE OF TYPE I COLLAGEN AS A USEFUL MARKER FOR MONITORING METASTATIC BONE ACTIVITY IN MEN WITH PROSTATE CANCERJournal of Urology, 2001
- Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate CancerJournal of Clinical Oncology, 1999
- A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.1998
- Quantitative bone metastases analysis based on image segmentation.1997
- Patterns of Bone Metastasis and their Prognostic Significance in Patients with Carcinoma of the ProstateBritish Journal of Urology, 1993
- Comparison of Phosphatase Isoenzymes PAP and PSA with Bone Scan in Patients with Prostate CarcinomaClinical Nuclear Medicine, 1991
- Independent Prognostic Factors in Patients With Metastatic (Stage D2) Prostate CancerJAMA, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Comparison of Enzyme, Clinical, Radiographic, and Radionuclide Methods of Detecting Bone Metastases from Carcinoma of the ProstateRadiology, 1976